Literature DB >> 1320395

An assessment of the ability of human bone marrow cultures to generate osteoclasts.

A M Flanagan1, M A Horton, E L Dorey, D A Collins, R S Evely, J M Moseley, F C Firkin, T J Chambers, M H Helfrich, T J Martin.   

Abstract

Several groups have successfully generated osteoclasts in cultures of murine haemopoietic cells. This approach would clearly be useful in the analysis of mechanisms of regulation of human osteoclast formation if analogous results could be obtained in cultures of human bone marrow. This communication describes independent attempts by three groups to generate unequivocally defined osteoclasts from bone marrow obtained from human iliac crest, femoral neck, rib, and from foetuses. The haemopoietic tissue was incubated using techniques described by others for production of osteoclast-like cells, and with variants of this technique using strategies based on our experiences with murine osteoclastogenesis. Haemopoietic cells were incubated with calcium regulating hormones, cytokines, osteoblastic supernatants, and osteoblastic or bone marrow stromal cell layers. Formation of cells capable of excavation of bone slices was rarely seen. Despite the paucity of bone resorbing cells, multinucleate cells (MNCs) developed with similar characteristics to the MNCs that have been interpreted as osteoclast-like in human bone marrow cultures. The MNCs were, however, calcitonin-receptor (CTR) negative, and did not show the typical pattern of reactivity with osteoclast-specific antibodies. They possessed instead an antigenic profile characteristic of macrophage polykaryons. We conclude that the MNCs which consistently generate in human bone marrow cultures do not possess phenotypic characteristics specific for osteoclasts and appear to be macrophage polykaryons. The conditions required for osteoclast generation in cultures of human haemopoietic cells remain to be defined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320395      PMCID: PMC2002338     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  45 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Histochemical demonstration of acid phosphatases with naphthol AS-phosphates.

Authors:  M S BURSTONE
Journal:  J Natl Cancer Inst       Date:  1958-09       Impact factor: 13.506

3.  Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue.

Authors:  A J Kahn; D J Simmons
Journal:  Nature       Date:  1975-11-27       Impact factor: 49.962

4.  Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells.

Authors:  M A Moore; H E Broxmeyer; A P Sheridan; P A Meyers; N Jacobsen; R J Winchester
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

5.  Calcitonin alters behaviour of isolated osteoclasts.

Authors:  T J Chambers; C J Magnus
Journal:  J Pathol       Date:  1982-01       Impact factor: 7.996

6.  Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.

Authors:  G Hattersley; T J Chambers
Journal:  J Cell Physiol       Date:  1990-01       Impact factor: 6.384

7.  Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures.

Authors:  T Akatsu; N Takahashi; K Debari; I Morita; S Murota; N Nagata; O Takatani; T Suda
Journal:  J Bone Miner Res       Date:  1989-02       Impact factor: 6.741

8.  1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism.

Authors:  E Abe; C Miyaura; H Tanaka; Y Shiina; T Kuribayashi; S Suda; Y Nishii; H F DeLuca; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.

Authors:  C Chenu; J Pfeilschifter; G R Mundy; G D Roodman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Effect of prostaglandins E1, E2, and F2 alpha on osteoclast formation in mouse bone marrow cultures.

Authors:  D A Collins; T J Chambers
Journal:  J Bone Miner Res       Date:  1991-02       Impact factor: 6.741

View more
  2 in total

1.  Effects of age and estrogen status on the skeletal IGF regulatory system. Studies with human marrow.

Authors:  C J Rosen; D Verault; C Steffens; D Cheleuitte; J Glowacki
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

2.  The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.

Authors:  A M Flanagan; M D Stow; N Kendall; W Brace
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.